Neuroprotective effect of ginger in the brain of streptozotocin-induced diabetic rats

Annals of Anatomy

Volumn 196, Issue 2-3, 2014, Pages 119-128

  El Akabawy, Gehan ^a   El Kholy, Wael ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Brain; Diabetes; Ginger; Histology; Immunohistochemistry

Indexed keywords

ACETYLCHOLINESTERASE; CASPASE 3; GLIAL FIBRILLARY ACIDIC PROTEIN; HERBACEOUS AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; KI 67 ANTIGEN; NEUROPROTECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN INJURY; CEREBELLUM; CONTROLLED STUDY; DEGENERATIVE DISEASE; DENTATE GYRUS; FRONTAL CORTEX; GINGER; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROGLIA; MALE; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; BIOSYNTHESIS; BLOOD; BRAIN; CHEMISTRY; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GLIOSIS; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOLOGY;

RATTUS; ZINGIBER OFFICINALE;

ACETYLCHOLINESTERASE; ANIMALS; APOPTOSIS; BLOOD GLUCOSE; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; GINGER; GLIOSIS; MALE; NEUROGENESIS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PLANT EXTRACTS; RATS;

EID: 84901271222     PISSN: 09409602     EISSN: 16180402     Source Type: Journal    
DOI: 10.1016/j.aanat.2014.01.003     Document Type: Article

References (71)

1. Abdulrazaq N.B., Cho M.M., Win N.N., Zaman R., Rahman M.T. Beneficial effects of ginger (Zingiber officinale) on carbohydrate metabolism in streptozotocin-induced diabetic rats. Br. J. Nutr. 2012, 108(7):1194-1201.
2. Ahmadpour S.H., Haghir H. Diabetes mellitus type 1 induces dark neuron formation in the dentate gyrus: a study by Gallyas' method and transmission electron microscopy. Rom. J. Morphol. Embryol. 2011, 52(2):575-579.
3. Anu J., Peeyush Kumar T., Nandhu M.S., Paulose C.S. Enhanced NMDAR1, NMDA2B and mGlu5 receptors gene expression in the cerebellum of insulin induced hypoglycaemic and streptozotocin induced diabetic rats. Eur. J. Pharmacol. 2010, 630(1-3):61-68.
4. Akhani S.P., Vishwakarma S.L., Goyal R.K. Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats. J. Pharm. Pharmacol. 2004, 56(1):101-105.
5. Appleyard M.E. Non-cholinergic functions of acetylcholinesterase. Biochem. Soc. Trans. 1994, 22:749-755.
6. Bajaj S., Khan A. Antioxidants and diabetes. Indian J. Endocrinol. Metab. 2012, 16(Suppl. 2):S267-S271.
7. Baluchnejadmojarad T., Roghani M. Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress. Behav. Brain Res. 2011, 224(2):305-310.
8. Baydas G., Nedzvetskii V.S., Tuzcu M., Yasar A., Kirichenko S.V. Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur. J. Pharmacol. 2003, 462(1-3):67-71.
9. Baydas G., Reiter R.J., Yasar A., Tuzcu M., Akdemir I., Nedzvetskii V.S. Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radic. Biol. Med. 2003, 35(7):797-804.
10. Bhutada P., Mundhada Y., Bansod K., Tawari S., Patil S., Dixit P., Umathe S., Mundhada D. Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behav. Brain Res. 2011, 220(1):30-41.
11. Birben E., Sahiner U.M., Sackesen C., Erzurum S., Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ. J. 2012, 5(1):9-19.
12. Black P.H. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med. hypotheses 2006, 67:879-891.
13. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
14. Celik S., Gorur S., Aslantas O., Erdogan S., Ocak S., Hakverdi S. Caffeic acid phenethyl ester suppresses oxidative stress in Escherichia coli-induced pyelonephritis in rats. Mol. Cell. Biochem. 2007, 297:131-138.
15. Chakraborty D., Mukherjee A., Sikdar S., Paul A., Ghosh S., Khuda-Bukhsh A.R. [6]-Gingerol isolated from ginger attenuates sodium arsenite induced oxidative stress and plays a corrective role in improving insulin signaling in mice. Toxicol. Lett. 2012, 210(1):34-43.
16. Comin D., Gazarini L., Zanoni J.N., Milani H., de Oliveira R.M. Vitamin E improves learning performance and changes the expression of nitric oxide-producing neurons in the brains of diabetic rats. Behav. Brain Res. 2010, 210:38-45.
17. Duarte J.M., Agostinho P.M., Carvalho R.A., Cunha R.A. Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice. PLoS ONE 2012, 7(4):e21899.
18. Edge J.A. Cerebral oedema during treatment of diabetic ketoacidosis: are we any nearer finding a cause?. Diabetes Metab. Res. Rev. 2000, 16(5):316-324.
19. Fukudome D., Matsuda M., Kawasaki T., Ago Y., Matsuda T. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice. Eur. J. Pharmacol. 2008, 583:164-169.
20. Gradinaru D., Borsa C., Ionescu C., Margina D. Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes. J. Proteomics 2013, 92:313-322.
21. Gebara B.M. Risk factors for cerebral edema in children with diabetic ketoacidosis. N. Engl. J. Med. 2001, 344(20):1556.
22. Gebel E. Diabetes on the brain. Diabetes Forecast 2012, 65(8):50-52.
23. Gurpinar T., Ekerbicer N., Uysal N., Barut T., Tarakci F., Tuglu M.I. The effects of the melatonin treatment on the oxidative stress and apoptosis in diabetic eye and brain. ScientificWorldJournal 2012, 2012:498489.
24. Habib S.H., Makpol S., Abdul Hamid N.A., Das S., Ngah W.Z., Yusof Y.A. Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics (Sao Paulo) 2008, 63(6):807-813.
25. Hamilton A., Patterson S., Porter D., Gault V.A., Holscher C. Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain. J. Neurosci. Res. 2011, 89(4):481-489.
26. Heimes K., Feistel B., Verspohl E.J. Impact of the 5-HT3 receptor channel system for insulin secretion and interaction of ginger extracts. Eur. J. Pharmacol. 2009, 624(1-3):58-65.
27. Hernandez-Fonseca J.P., Rincon J., Pedreanez A., Viera N., Arcaya J.L., Carrizo E., Mosquera J. Structural and ultrastructural analysis of cerebral cortex, cerebellum, and hypothalamus from diabetic rats. Exp. Diabetes Res. 2009, 2009:329632.
28. Huang C.N., Horng J.S., Yin M.C. Antioxidative and antiglycative effects of six organosulfur compounds in low-density lipoprotein and plasma. J. Agric. Food Chem. 2004, 52(11):3674-3678.
29. Hoffman W.H., Cudrici C.D., Zafranskaia E., Rus H. Complement activation in diabetic ketoacidosis brains. Exp. Mol. Pathol. 2006, 80(3):283-288.
30. Jackson-Guilford J., Leander J.D., Nisenbaum L.K. The effect of streptozotocin-induced diabetes on cell proliferation in the rat dentate gyrus. Neurosci. Lett. 2000, 293(2):91-94.
31. Jing Y.H., Chen K.H., Kuo P.C., Pao C.C., Chen J.K. Neurodegeneration in streptozotocin-induced diabetic rats is attenuated by treatment with resveratrol. Neuroendocrinology 2013, 10:28.
32. Jolad S.D., Lantz R.C., Chen G.J., Bates R.B., Timmermann B.N. Commercially processed dry ginger (Zingiber officinale): composition and effects on LPS-stimulated PGE2 production. Phytochemistry 2005, 66(13):1614-1635.
33. Kaneko K., Nakamura A., Yoshida K., Kametani F., Higuchi K., Ikeda S. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free Radic. Res. 2002, 36(3):303-306.
34. Kamboj S.S., Sandhir R. Protective effect of N-acetylcysteine supplementation on mitochondrial oxidative stress and mitochondrial enzymes in cerebral cortex of streptozotocin-treated diabetic rats. Mitochondrion 2011, 11(1):214-222.
35. Kavalali G., Tuncel H., Goksel S., Hatemi H.H. Hypoglycemic activity of Urtica pilulifera in streptozotocin-diabetic rats. J. Ethnopharmacol. 2003, 84(2-3):241-245.
36. Kee N., Sivalingam S., Boonstra R., Wojtowicz J.M. The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J. Neurosci. Methods 2002, 115(1):97-105.
37. Kolacek M., Muchova J., Vrankova S., Jendekova L., Pechanova O., Ulicna O., Watala C., Durackova Z. Effect of natural polyphenols, pycnogenol (R) on superoxide dismutase and nitric oxide synthase in diabetic rats. Prague Med. Rep. 2010, 111(4):279-288.
38. Kuhad A., Sethi R., Chopra K. Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sci. 2008, 83:128-134.
39. Kumar A., Haroon E., Darwin C., Pham D., Ajilore O., Rodriguez G., Mintz J. Gray matter prefrontal changes in type 2 diabetes detected using MRI. J. Magn. Reson. Imaging 2008, 27(1):14-19.
40. Kumar P.T., George N., Antony S., Paulose C.S. Curcumin restores diabetes induced neurochemical changes in the brain stem of Wistar rats. Eur. J. Pharmacol. 2013, 702:323-331.
41. Li Y., Tran V.H., Duke C.C., Roufogalis B.D. Preventive and protective properties of Zingiber officinale (ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review. Evid. Based Complement Alternat. Med. 2012, 2012:516870.
42. Liu Y., Tian X., Gou L., Sun L., Ling X., Yin X. Luteolin attenuates diabetes-associated cognitive decline in rats. Brain Res. Bull. 2013, 94:23-29.
43. Liu J.P., Feng L., Zhang M.H., Ma D.Y., Wang S.Y., Gu J., Fu Q., Qu R., Ma S.P. Neuroprotective effect of Liuwei Dihuang decoction on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat. J. Ethnopharmacol. 2013, (in press).
44. Liapi C., Kyriakaki A., Zarros A., Galanopoulou P., Al-Humadi H., Dontas I., Voumvourakis K., Tsakiris S. Choline-deprivation alters crucial brain enzyme activities in a rat model of diabetic encephalopathy. Metab. Brain Dis. 2010, 25:269-276.
45. Northam E.A., Cameron F.J. Understanding the diabetic brain: new technologies but old challenges. Diabetes 2013, 62(2):341-342.
46. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
47. Pamidi N., Satheesha Nayak B.N. Effect of streptozotocin induced diabetes on rat hippocampus. Bratisl. Lek. Listy 2012, 113(10):583-588.
48. Peeyush, Kumar T., Antony S., Soman S., Kuruvilla K.P., George N., Paulose C.S. Role of curcumin in the prevention of cholinergic mediated cortical dysfunctions in streptozotocin-induced diabetic rats. Mol. Cell. Endocrinol. 2011, 331:1-10.
49. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50(4):427-434.
50. Perkins B.A., Bril V. Emerging therapies for diabetic neuropathy: a clinical overview. Curr. Diabetes Rev. 2005, 1(3):271-280.
51. Rajashree R., Kholkute S.D., Goudar S.S. Effects of duration of diabetes on behavioural and cognitive parameters in streptozotocin-induced juvenile diabetic rats. Malays. J. Med. Sci. 2011, 18(4):26-31.
52. Ray K.K., Seshasai S.R., Wijesuriya S., Sivakumaran R., Nethercott S., Preiss D., Erqou S., Sattar N. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009, 373(9677):1765-1772.
53. Sandhir R., Julka D., Gill K.D. Lipoperoxidative damage on lead exposure in rat brain and its implications on membrane bound enzymes. Pharmacol. Toxicol. 1994, 74:66-71.
54. Schram M.T., Chaturvedi N., Schalkwijk C.G. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1diabetes - the EURODIAB prospective complications study. Diabetologia 2005, 48:370-378.
55. Schmatz R., Mazzanti C.M., Spanevello R., Stefanello N., Gutierres J., Correa M., da Rosa M.M., Rubin M.A., Chitolina Schetinger M.R., Morsch V.M. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 2009, 610:42-48.
56. Shanmugam K.R., Ramakrishna C.H., Mallikarjuna K., Reddy K.S. Protective effect of ginger against alcohol-induced renal damage and antioxidant enzymes in male albino rats. Indian J. Exp. Biol. 2010, 48(2):143-149.
57. Shanmugam K.R., Mallikarjuna K., Kesireddy N., Sathyavelu, Reddy K. Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats. Food Chem. Toxicol. 2011, 49(4):893-897.
58. Sherin A., Anu J., Peeyush K.T., Smijin S., Anitha M., Roshni B.T., Paulose C.S. Cholinergic and GABAergic receptor functional deficit in the hippocampus of insulin-induced hypoglycemic and streptozotocin-induced diabetic rats. Neuroscience 2012, 202:69-76.
59. Shi X., Chen Y., Nadeem L., Xu G. Beneficial effect of TNF-alpha inhibition on diabetic peripheral neuropathy. Journal of neuroinflammation 2013, 10:69.
60. Shingo A.S., Kanabayashi T., Murase T., Kito S. Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signalling through the dentate gyrus. Behav. Brain Res. 2012, 229(2):378-383.
61. Simmons R.A. Developmental origins of diabetes: the role of oxidative stress. Best Pract. Res. Clin. Endocrinol. Metab. 2012, 26(5):701-708.
62. Suge R., Shimazu T., Hasegawa H., Inoue I., Hayashibe H., Nagasaka H., Araki N., Katayama S., Nomura M., Watanabe S. Cerebral antioxidant enzyme increase associated with learning deficit in type 2 diabetes rats. Brain Res. 2012, 1481:97-106.
63. Thakur A.K., Chatterjee S.S., Kumar V. Beneficial effects of Brassica juncea on cognitive functions in rats. Pharm. Biol. 2013, 51:1304-1310.
64. Tsakanova G.V., Ayvazyan V.A., Boyajyan A.S., Arakelova E.A., Grigoryan G.S., Guevorkyan A.A., Mamikonyan A.A. A comparative study of antioxidant system and intensity of lipid peroxidation in type 2 diabetes mellitus and ischemic stroke aggravated and not aggravated by type 2 diabetes mellitus. Bull. Exp. Biol. Med. 2011, 151(5):564-566.
65. Vignini A., Giulietti A., Nanetti L., Raffaelli F., Giusti L., Mazzanti L., Provinciali L. Alzheimer's disease and diabetes: new insights and unifying therapies. Curr. Diabetes Rev. 2013, 9(3):218-227.
66. Venturini C.D., Merlo S., Souto A.A., Fernandes Mda C., Gomez R., Rhoden C.R. Resveratrol and red wine function as antioxidants in the nervous system without cellular proliferative effects during experimental diabetes. Oxid. Med. Cell. Longev. 2010, 3(6):434-441.
67. Vincent A.M., Russell J.W., Low P., Feldman E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev. 2004, 25:612-628.
68. Young H.Y., Luo Y.L., Cheng Y., Hsieh W.C., Liao J.C., Peng W.H. Analgesic and anti-inflammatory activities of [6]-gingerol. J. Ethnopharmacol. 2005, 96(1-2):207-210.
69. Zhang W.J., Tan Y.F., Yue J.T., Vranic M., Wojtowicz J.M. Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats. Acta Neurol. Scand. 2008, 117(3):205-210.
70. Zhang X.F., Tan B.K. Antihyperglycaemic and anti-oxidant properties of Andrographis paniculata in normal and diabetic rats. Clin. Exp. Pharmacol. Physiol. 2000, 27(5-6):358-363.
71. Zhao B., Pan B.S., Shen S.W., Sun X., Hou Z.Z., Yan R., Sun F.Y. Diabetes-induced central neuritic dystrophy and cognitive deficits are associated with the formation of oligomeric reticulon-3 via oxidative stress. J. Biol. Chem. 2013, 288:15590-15599.